Cemiplimab
Generic Name	Cemiplimab
Trade Name	Libtayo
Company Name	Cemiplimab (REGN2810)
Drug Type	Immunotherapy (PD‐1 inhibitor)
Drug Class	Immune therapy
Dose	3 milligrams (mg) per kilogram (kg)
Route	i.v.
Schedule of Administration	Every 2 weeks for up to 48 weeks (up to six cycles [cycle = 56 days]).
GM‐CSF
Generic Name	GM‐CSF
Company Name	GM‐CSF
Drug Type	Immunostimulatory
Drug Class	Immune therapy
Dose	250 mcg per m2
Route	i.v.
Schedule of Administration	Daily in the first 7 days of a 2‐week cycle, for a total of four cycles.
Cyclophosphamide
Generic Name	Cyclophosphamide
Trade Name	Cyclophosphamide
Company Name
Drug Type	Alkylating chemotherapy
Drug Class	Alkylating agent
Dose	200 milligrams (mg) per squared meter (m2)
Route	i.v.
Schedule of Administration	Every 14 days for a total of four doses. In addition to cemiplimab, GM‐CSF, and cyclophosphamide treatment included palliative radiation (27 Gy: 9 Gy × 3 over 1 week, starting 1 week after first dose of cemiplimab).